Clinical and Epidemiological Features of Patients with Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Iran: Different Points of Children from Adults.


Journal

International journal of pediatrics
ISSN: 1687-9740
Titre abrégé: Int J Pediatr
Pays: Egypt
ID NLM: 101517077

Informations de publication

Date de publication:
2022
Historique:
received: 21 09 2021
revised: 25 12 2021
accepted: 19 01 2022
entrez: 18 2 2022
pubmed: 19 2 2022
medline: 19 2 2022
Statut: epublish

Résumé

Different epidemiologic aspects of drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in children are scarce. To compare the clinical and epidemiological features of patients with drug-induced SJS and TEN in children and adults. This retrospective study was conducted at two academic referral centers (Isfahan, Iran) over 5 years. SJS and TEN were clinically diagnosed and confirmed by skin biopsy as needed. One hundred one patients (31 children and 70 adults) with a female to male ratio of 1.1 : 1 was identified in the present study. SJS was more commonly diagnosed in both pediatric and adult patients. The most frequent reason for drug administration identified was the infection (45.2%) and seizure (45.2%) in children and infection (34.3%) and psychiatry disorder (27.1%) in adults ( The present study showed several differences between the pediatric and adult patients with SJS and TEN, including the reason for drug administration, culprit drugs, length of hospital stay, presence of fever, and final diagnosis of disease.

Sections du résumé

BACKGROUND BACKGROUND
Different epidemiologic aspects of drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in children are scarce.
AIM OBJECTIVE
To compare the clinical and epidemiological features of patients with drug-induced SJS and TEN in children and adults.
METHOD METHODS
This retrospective study was conducted at two academic referral centers (Isfahan, Iran) over 5 years. SJS and TEN were clinically diagnosed and confirmed by skin biopsy as needed.
RESULTS RESULTS
One hundred one patients (31 children and 70 adults) with a female to male ratio of 1.1 : 1 was identified in the present study. SJS was more commonly diagnosed in both pediatric and adult patients. The most frequent reason for drug administration identified was the infection (45.2%) and seizure (45.2%) in children and infection (34.3%) and psychiatry disorder (27.1%) in adults (
CONCLUSIONS CONCLUSIONS
The present study showed several differences between the pediatric and adult patients with SJS and TEN, including the reason for drug administration, culprit drugs, length of hospital stay, presence of fever, and final diagnosis of disease.

Identifiants

pubmed: 35178096
doi: 10.1155/2022/8163588
pmc: PMC8847037
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8163588

Informations de copyright

Copyright © 2022 Bahareh Abtahi-Naeini et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this paper.

Références

Am J Ophthalmol. 2018 May;189:17-28
pubmed: 29421293
J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):38-69
pubmed: 29310768
World J Pediatr. 2017 Jun;13(3):255-260
pubmed: 27650525
Iran J Med Sci. 2018 Jul;43(4):421-425
pubmed: 30046212
Cornea. 2016 Jan;35(1):46-50
pubmed: 26555585
J Burn Care Res. 2015 Jan-Feb;36(1):167-77
pubmed: 25559731
Ocul Surf. 2016 Jan;14(1):2-19
pubmed: 26549248
J Invest Dermatol. 2016 Jul;136(7):1387-1397
pubmed: 27039263
Arch Dermatol. 1993 Jan;129(1):92-6
pubmed: 8420497
Clin Infect Dis. 2011 May;52 Suppl 4:S284-9
pubmed: 21460286
Br J Ophthalmol. 2007 Aug;91(8):1048-53
pubmed: 17314145
J Res Med Sci. 2014 Aug;19(8):720-5
pubmed: 25422656
Cutan Ocul Toxicol. 2021 Sep;40(3):280-292
pubmed: 34152866
Allergy. 2007 May;62(5):527-31
pubmed: 17313402
Res Dev Disabil. 2011 Nov-Dec;32(6):2660-8
pubmed: 21752594
Pediatrics. 2011 Oct;128(4):723-8
pubmed: 21890829
Am J Clin Dermatol. 2015 Dec;16(6):475-93
pubmed: 26481651
Am J Ophthalmol. 2016 Jun;166:68-75
pubmed: 27018234
Burns. 2020 Jun;46(4):959-969
pubmed: 31898979
Clin Rev Allergy Immunol. 2018 Feb;54(1):147-176
pubmed: 29188475
J Postgrad Med. 2011 Apr-Jun;57(2):115-9
pubmed: 21654132
Int J Dermatol. 2019 Sep;58(9):1069-1077
pubmed: 30825193
Pediatr Dermatol. 2017 Jul;34(4):433-437
pubmed: 28508417
Orphanet J Rare Dis. 2010 Dec 16;5:39
pubmed: 21162721
Pediatr Dermatol. 2018 Mar;35(2):182-187
pubmed: 29315761
Acta Derm Venereol. 2007;87(2):144-8
pubmed: 17340021
Pediatrics. 2009 Feb;123(2):e297-304
pubmed: 19153164
Pediatr Infect Dis J. 2017 May;36(5):513-515
pubmed: 28403057
J Am Acad Dermatol. 2017 May;76(5):811-817.e4
pubmed: 28285784
Am J Health Syst Pharm. 2010 Feb 1;67(3):206-13
pubmed: 20101062

Auteurs

Bahareh Abtahi-Naeini (B)

Pediatric Dermatology Division of Department of Pediatrics, Imam Hossein Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Mohammad-Sadegh Dehghan (MS)

Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Fatemeh Paknazar (F)

Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran.

Zabihollah Shahmoradi (Z)

Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Gita Faghihi (G)

Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Ali Mohammad Sabzghabaee (AM)

Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Mojtaba Akbari (M)

Department of Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.

Mahdi Hadian (M)

Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Tooba Momen (T)

Department of Allergy and Clinical Immunology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Classifications MeSH